A genome-wide increase in chromatin accessibility was also observed in SETD2-deficient human ccRCC and primary mouse renal tubular epithelial cells compared with respective SETD2-proficient counterparts (29), indicating that increased chromatin accessibility is a primary phenotype caused by SETD2 loss across different tissue types. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.